...
首页> 外文期刊>Journal of Clinical Microbiology >In Vitro Susceptibilities of Yeast Species to Fluconazole and Voriconazole as Determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study
【24h】

In Vitro Susceptibilities of Yeast Species to Fluconazole and Voriconazole as Determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study

机译:根据2010年中国国家医院侵入性真菌监测网(CHIF-NET)研究确定,酵母菌对氟康唑和伏立康唑的体外敏感性

获取原文
           

摘要

We conducted active, laboratory-based surveillance for isolates from patients with invasive infections across China from August 2009 to July 2010. DNA sequencing methods were used to define species, and susceptibility to fluconazole and voriconazole was determined by the Clinical and Laboratory Standards Institute M44-A2 disk diffusion method but using up-to-date clinical breakpoints or epidemiological cutoff values. Candida spp. made up 90.5% of the 814 yeast strains isolated, followed by Cryptococcus neoformans (7.7%) and other non-Candida yeast strains (1.7%). Bloodstream isolates made up 42.9% of the strains, isolates from ascitic fluid made up 22.1%, but pus/tissue specimens yielded yeast strains in <5% of the cases. Among the Candida isolates, Candida albicans was the most common species from specimens other than blood (50.1%) but made up only 23% of the bloodstream isolates (P < 0.001). C. parapsilosis complex species were the most common Candida isolates from blood (33.2%). Uncommon bloodstream yeast strains included Trichosporon spp., C. pelliculosa, and the novel species C. quercitrusa, reported for the first time as a cause of candidemia. Most (>94%) of the isolates of C. albicans, C. tropicalis, and the C. parapsilosis complex were susceptible to fluconazole and voriconazole, as were all of the Trichosporon strains; however, 12.2% of the C. glabrata sensu stricto isolates were fluconazole resistant and 17.8% had non-wild-type susceptibility to voriconazole. Seven C. tropicalis strains were cross-resistant to fluconazole and voriconazole; six were from patients in the same institution. Resistance to fluconazole and voriconazole was seen in 31.9% and 13.3% of the uncommon Candida and non-Candida yeast strains, respectively. Causative species and azole susceptibility varied with the geographic region. This study provided clinically useful data on yeast strains and their antifungal susceptibilities in China.
机译:我们从2009年8月至2010年7月在全国范围内对来自侵入性感染患者的分离株进行了基于实验室的积极监测。使用DNA测序方法确定物种,并通过临床和实验室标准协会M44-确定对氟康唑和伏立康唑的敏感性。 A2磁盘扩散方法,但使用最新的临床断点或流行病学临界值。念珠菌属在分离的814株酵母菌中占90.5%,其次是新隐球菌(7.7%)和其他非Candida酵母菌(1.7%)。血流分离株占菌株的42.9%,腹水分离株占22.1%,但脓液/组织标本产生酵母菌株的比例小于5%。在念珠菌分离物中,白色念珠菌是血液中标本中最常见的物种(50.1%),但仅占血液分离物的23%( P <0.001)。 C. parapsilosis复杂物种是血液中最常见的念珠菌分离株(33.2%)。罕见的血流酵母菌株包括Trichosporon spp。,C。pelliculosa和新物种quercitrusa,这是首次报告为念珠菌血症的原因。大多数白色念珠菌,热带念珠菌和副念珠菌复合体的分离株(> 94%)对氟康唑和伏立康唑敏感,对所有的Trichosporon菌株也是如此。但是,有12.2%的C. glabrata sensu stricto菌株对氟康唑耐药,而17.8%的患者对伏立康唑具有非野生型敏感性。七株热带念珠菌对氟康唑和伏立康唑具有交叉耐药性;六名来自同一机构的患者。在罕见的念珠菌和非念珠菌菌株中分别观察到对氟康唑和伏立康唑的耐药性,分别为31.9%和13.3%。致病菌种和唑类敏感性随地理区域而异。该研究为中国的酵母菌株及其抗真菌药性提供了临床有用的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号